Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine.
Autor: | Propper, D J, Braybrooke, J P, Levitt, N C, O’Byrne, K, Christodoulos, K, Han, C, Talbot, D C, Ganesan, T S, Harris, A L |
---|---|
Zdroj: | British Journal of Cancer. 6/1/2000, Vol. 82 Issue 11, p1759. 5p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |